Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin M Warren

Showing results (21-30 of 236) with videos related to

Pageof 24
Sort By:
Plos One|July 7, 2018
Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosisDanicke Willemse, Brandon Weber, Laura Masino, et al.
BMC Evolutionary Biology|September 23, 2009
Evidence for a rapid rate of molecular evolution at the hypervariable and immunogenic Mycobacterium tuberculosis PPE38 gene regionChristopher R E McEvoy, Paul D van Helden, Robin M Warren, et al.
Tuberculosis (Edinburgh, Scotland)|September 8, 2009
Multiple, independent, identical IS6110 insertions in Mycobacterium tuberculosis PPE genesChristopher R E McEvoy, Robin M Warren, Paul D van Helden, et al.
Molecular Diagnosis & Therapy|September 15, 2011
Detecting drug-resistant tuberculosis: the importance of rapid testingKim G P Hoek, Annelies Van Rie, Paul D van Helden, et al.
Veterinary Immunology and Immunopathology|April 20, 2016
The stability of plasma IP-10 enhances its utility for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)Wynand J Goosen, Paul D van Helden, Robin M Warren, et al.
Expert Review of Anti-Infective Therapy|April 21, 2011
Tuberculosis assays: past, present and futureNovel N Chegou, Kim G P Hoek, Magdalena Kriel, et al.
The Pediatric Infectious Disease Journal|August 12, 2005
Recurrent culture-confirmed tuberculosis in human immunodeficiency virus-infected childrenH Simon Schaaf, Sara Krook, Dete W Hollemans, et al.
Tuberculosis (Edinburgh, Scotland)|September 25, 2007
Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial repliconWilliam R Bourn, Yvette Jansen, Helen Stutz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2011
Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South AfricaKaren R Jacobson, Danie Theron, Thomas C Victor, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Moxifloxacin retains antimycobacterial activity in the presence of gyrA mutationsMarieta McGrath, Nico C Gey van Pittius, Frederick A Sirgel, et al.
Pageof 24

Showing results (21-30 of 236) with videos related to

Sort By:
Pageof 24
Plos One|July 7, 2018
Rv1460, a SufR homologue, is a repressor of the suf operon in Mycobacterium tuberculosisDanicke Willemse, Brandon Weber, Laura Masino, et al.
BMC Evolutionary Biology|September 23, 2009
Evidence for a rapid rate of molecular evolution at the hypervariable and immunogenic Mycobacterium tuberculosis PPE38 gene regionChristopher R E McEvoy, Paul D van Helden, Robin M Warren, et al.
Tuberculosis (Edinburgh, Scotland)|September 8, 2009
Multiple, independent, identical IS6110 insertions in Mycobacterium tuberculosis PPE genesChristopher R E McEvoy, Robin M Warren, Paul D van Helden, et al.
Molecular Diagnosis & Therapy|September 15, 2011
Detecting drug-resistant tuberculosis: the importance of rapid testingKim G P Hoek, Annelies Van Rie, Paul D van Helden, et al.
Veterinary Immunology and Immunopathology|April 20, 2016
The stability of plasma IP-10 enhances its utility for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)Wynand J Goosen, Paul D van Helden, Robin M Warren, et al.
Expert Review of Anti-Infective Therapy|April 21, 2011
Tuberculosis assays: past, present and futureNovel N Chegou, Kim G P Hoek, Magdalena Kriel, et al.
The Pediatric Infectious Disease Journal|August 12, 2005
Recurrent culture-confirmed tuberculosis in human immunodeficiency virus-infected childrenH Simon Schaaf, Sara Krook, Dete W Hollemans, et al.
Tuberculosis (Edinburgh, Scotland)|September 25, 2007
Creation and characterisation of a high-copy-number version of the pAL5000 mycobacterial repliconWilliam R Bourn, Yvette Jansen, Helen Stutz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2011
Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South AfricaKaren R Jacobson, Danie Theron, Thomas C Victor, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2014
Moxifloxacin retains antimycobacterial activity in the presence of gyrA mutationsMarieta McGrath, Nico C Gey van Pittius, Frederick A Sirgel, et al.
Pageof 24